Global Organ Preservation Solution Market: Snapshot

The global organ preservation solutions market is expected to rise substantially during the forecast period owing to increasing number of opportunities due to strategic partnership with medical institution and research organizations. Rise in advanced technology in medical sector will supplement the market growth. Various nations globally are showing upswing in per capita healthcare expenditure which can boost the market growth in the coming years. Increasing geriatric population is augmenting the global market for organ preservation solutions. Rising number of government and NGO initiatives to promote organ donation is one of the prime reasons for growth of the market. This has led to increasing amount of solid organ transplantation procedures in the healthcare sector. Moreover, rise in failure of organ is fueling the global organ preservation solutions market.

According to a report by Transparency Market Research, the global organ preservation solutions market is anticipated to rise at a tremendous CAGR of 16.50% during the forecast period of 2013 to 2019. The global market was worth US$0.06 bn during 2012 and is expected to attain a valuation of US$0.20 bn by the end of the forecast period.

Rise in Number of Organ Failures to Boost the Global Organ Preservation Solutions Market

The global organ preservation solutions segment is divided into siRNA transplant solutions, Human Biosystems solution (HBS), RENOGRAPF, hypothermosol, lifor, PERFADEX, custodiol HTK solution, and viaspan. Among these, Custodiol HTK Solution held the largest amount of shares in 2012 and is anticipated to grow in the forecast period. Rise in preservation of various organs such as kidneys, pancreas, liver, and lungs are the prime reason for the rise of this segment in the global organ preservation solutions market.

The global organ preservation technique segment is divided into static cold storage and hypothermic perfusion preservation. Among these, the preservation technique segment is led by static cold storage. This segment is rising in demand owing to its user friendly and cost effective techniques for physicians. However, hypothermic perfusion preservation is expected to experience higher demand during the forecast period due to the benefits of organ preservation it provides for longer period. Moreover, organ donors are decreasing in count and demands for organs are rising globally thus, leading to rise in demand for hypothermic perfusion preservation.

Rising Organ Donors to Supplement Growth of Europe Organ Preservation Solutions Market

The global organ preservation solutions market is spread across various regions such as Asia Pacific, Europe, North America, and rest of the world. The global market was dominated by Europe in 2012. This region is likely to be in the lead in the coming few years due to technological advancement rapidly increasing in this region. The European market for organ preservation solution is expected to progress at a steady rate during the forecast period. Spain is contributing substantially to the European market. This in one of the leading factor for rise of organ preservation solutions in this region. Europe market is also witnessing rise in number of organ donors and the policy of being an organ donor are promoting the growth in this region. The rise in demand for organ donation in this region is supplementing the demand for the market. Rise in government initiatives encouraging organ donation is another factor leading to the rise in market of the organ preservation solutions.

Some of the leading companies operating in the global organ preservation solutions market are CryoLife, Inc., Lifeline Scientific, BioTime, Inc., Claris Lifesciences Limited, and BioLife Solutions, Inc.

 

Organ preservation solutions are used to preserve organs before transplantation procedure as these organs in external climate are vulnerable and also become dysfunctional once taken out from the human body. To preserve and maintain organs functionality for their further usage such as transplantation and research, organ preservation solutions are used. Increasing demand for organ transplantation procedures across the globe is expected to drive the growth of organ preservation solutions market. In addition, aging population will also propel the growth of organ preservation solutions market as the risk of organ failure in elderly people increases that augments the demand for organ transplants. Likewise, development of technologically advanced solutions for preserving organs will further accentuate the growth of organ preservation solutions market.

 

This report studies the global organ preservation solutions market based on the various solutions available in the market in which organs are preserved. These solutions include Viaspan, Custodiol HTK, Renograf, Hypothermosol, Perfadex, Lifor, HBS Solution, siRNA Transplant Solution and others (Ross-Marshall Citrate Solutions, Celsior Solution, Phosphate-Buffered Sucrose Solution, ET-Kyoto, TranSend, HetaFreeze, MaPersol and CryoStor). The market for these solutions has been extensively analyzed based on number of organ transplant, efficiency and application area. The market size and forecast in terms of USD million for each product type has been provided for the period 2011 to 2019, considering 2012 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2013 to 2019 for each segment.

 

Based on the type of preservation techniques used to preserve organs, market has been segmented as hypothermic perfusion preservation (HPP), static cold storage (SCS) and others (that include normothermic preservation and oxygen insufflation techniques). The market for these technologies has been extensively analyzed based on number of organ transplant, compatibility with solution and organs, and cost. The market size and forecast in terms of USD million for each product type has been provided for the period 2011 to 2019, considering 2012 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2013 to 2019 for each segment.

 

Geographically, the report studies the global market with respect to four main regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecasts in terms of revenue (USD million) for the period 2011 to 2019, considering 2012 as the base year, have been provided for this segment. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2013 to 2019 for each segment.

 

The market overview section of the report discusses the market dynamics that include drivers, restraints and opportunities influencing the market. In addition, major events have also been discussed in the section that have boosted the growth of the market and expected to further propel the growth during the forecast period. Also, this section covers market attractiveness analysis (by geography) for the year 2012 and Porter’s five forces analysis for the global ultrasound devices market. Market share (%) by revenue for the major players operating in this market has also been provided for the year 2012 in the competitive landscape section, followed by a list of recommendations for the existing and new players. In addition, the report also profiled key players of the market on various parameters such as business overview, financial overview, product portfolio, business strategies and recent developments of the respective company. Some of the prominent players in the organ preservation solutions market that have been profiled in this report include Dr. Franz Köhler Chemie GmbH, Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb, BioLife Solutions, Inc., XVIVO Perfusion AB and ToleroTech, Inc.

 

The global organ preservation solutions market has been segmented as below:

 

Organ Preservation Solutions Market, by Solution 

  • Viaspan
  • Custodiol HTK (Histidine-Tryptophan-Ketoglutarate) Solution
  • RENOGRA
  • HypoThermosol
  • PERFADEX
  • Lifor
  • Human BioSystems (HBS) Solution
  • siRNA Transplant Solutions
  • Others

Organ Preservation Solutions Market, by Preservation Technique

  • Hypothermic Perfusion Preservation (HPP)
  • Static Cold Storage (SCS)
  • Others 

Organ Preservation Solutions Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)
.